Gene · 10112
Papers1,613
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,613
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A competing TMPO-AS1-let-7b-5p-kinesin superfamily RNA network predicts poor lung cancer patient survival. | Rep Pract Oncol Radiother | 2026 | 41937877 | PubTator, text mining | PubMed |
| Lactate drives immune resistance via a pharmaceutically reversible H3K18la-KIF20A-c-Myc-PD-L1 axis in hepatocellular carcinoma. | Cancer Biol Med | 2026 | 41937416 | PubTator, text mining | PubMed |
| Spatial multi-omics characterization of neuroblastoma reveals ferroptosis-associated metabolic features in high-risk tumors. | Genome Med | 2026 | 41918107 | PubTator, text mining | PubMed |
| RNA N6-methyladenosine (m6A) regulates cell cycle progression in diffuse midline glioma (DMG) and confers sensitivity to FTO inhibition. | Cell Death Dis | 2026 | 41888518 | PubTator, text mining | PubMed |
| Integrative computational pipeline for the in silico prioritization of potential KIF11-targeting drug candidates in glioblastoma. | J Mol Graph Model | 2026 | 41850152 | PubTator, text mining | PubMed |
| Targeting Autophagy in Ovarian Cancer: The Emerging Role of Ginsenosides. | Cancer Med | 2026 | 41811763 | PubTator, text mining | PubMed |
| CENPF Promotes Gastric Cancer Proliferation through c-Myc-Mediated GLS1 Upregulation and Glutamine Metabolism. | Oncol Res | 2026 | 41799529 | PubTator, text mining | PubMed |
| Prognostic stratification in hepatocellular carcinoma using a telomerase-related lncRNA signature derived from TCGA database. | PLoS One | 2026 | 41790716 | PubTator, text mining | PubMed |
| Correction to "KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells". | Dis Markers | 2026 | 41783332 | PubTator, text mining | PubMed |
| Emerging roles of RNA N5-methylcytosine modification in reproductive physiology and gynecological diseases. | Epigenetics | 2026 | 41778387 | PubTator, text mining | PubMed |
| KIF20A promotes cervical cancer progression by interacting with CLIP1. | Sci Rep | 2026 | 41776329 | PubTator, text mining | PubMed |
| Integrated bioinformatic analysis identifies ferroptosis-related biomarkers and subtypes in invasive aspergillosis. | Toxicol Res (Camb) | 2026 | 41756099 | PubTator, text mining | PubMed |
| Retraction: Long noncoding RNA LSINCT5 promotes endometrial carcinoma cell proliferation, cycle, and invasion by promoting the Wnt/β-catenin signaling pathway via HMGA2. | Ther Adv Med Oncol | 2026 | 41756066 | PubTator, text mining | PubMed |
FOXM1 Signaling Network Transcriptionally Upregulates Expression of Proteins Involved in Mitotic Progression to Induce High Proliferation and Chromosomal Instability in Androgen Receptor-Low Triple-Negative Breast Cancer. | Int J Mol Sci | 2026 | 41751958 | PubTator, text mining | PubMed |
| KIF18B Is Essential for Lung Adenocarcinoma Progression Through the E2F Transcriptional Network. | Int J Mol Sci | 2026 | 41751942 | PubTator, text mining | PubMed |
| Low KIF26B Expression Reduces Paclitaxel Resistance and Predicts Good Prognosis in Ovarian Cancer. | Curr Issues Mol Biol | 2026 | 41751488 | PubTator, text mining | PubMed |
| Harnessing Vaccines in the Treatment of Solid Tumors: Advances, Challenges, and Future Directions. | Vaccines (Basel) | 2026 | 41746058 | PubTator, text mining | PubMed |
| Cancer neuroscience: signaling pathways and new therapeutic strategies for cancer. | Signal Transduct Target Ther | 2026 | 41724757 | PubTator, text mining | PubMed |
| FOXM1 induces therapy resistance and inhibits apoptosis in a variety of human cancers. | Cell Death Dis | 2026 | 41714589 | PubTator, text mining | PubMed |
| FOXK1 induced upregulation of KIF20A promotes hepatocellular carcinoma progression via Wnt/β-Catenin/EMT signaling. | Cell Mol Life Sci | 2026 | 41714472 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10112/papers?page=2